Esperanza Garcia
Mexico City, DIF 14269, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice.
Journal: Molecular neurobiology
Published: February 07, 2023
Oral Silica Nanoparticles Lack of Neurotoxic Effects in a Parkinson's Disease Model: A Possible Nanocarrier?
Journal: IEEE transactions on nanobioscience
Published: August 10, 2019
Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model.
Journal: Oxidative medicine and cellular longevity
Published: July 29, 2019
The Antiepileptic Drug Levetiracetam Protects Against Quinolinic Acid-Induced Toxicity in the Rat Striatum.
Journal: Neurotoxicity research
Published: August 20, 2017
URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors.
Journal: Neurotoxicity research
Published: October 17, 2016
Neuroprotective effect of thalidomide on MPTP-induced toxicity.
Journal: Neurotoxicology
Published: November 21, 2014
S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2.
Journal: Free radical research
Published: October 24, 2013
Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Journal: Toxicology
Published: August 23, 2013
An enteric nervous system progenitor cell implant promotes a behavioral and neurochemical improvement in rats with a 6-OHDA-induced lesion.
Journal: Neurotoxicology and teratology
Published: July 30, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026